Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Clinical trial NCT01075425 · COMPLETED
Trial details
- NCT number
- NCT01075425
- Sponsor
- Virginia Commonwealth University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2015-02-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.